Dr Maria Beaumont – Scientific Meetings Secretary
Following a 1st class Hons degree in Combined Studies in Biology (Toxicology major) and Chemistry, an MSc in Toxicology and a PhD in Biological Sciences (kidney toxicology in vivo – assessed by metabonomics and traditional toxicity measures) I undertook 6 years of post doctoral research assignments in the toxicology and technology fields. I was a Wellcome Trust Research Fellow (kidney toxicity in vitro – metabonomics) and followed this with just under 3 years as an EU post doctoral researcher in the Biochemistry department of the University of Cambridge investigating apoptosis. I was a member of the Safety Assessment Division at GSK from 1999 to 2016 working in various investigative (Metabolic Profiling; Metabonomic; In Vivo Biomarkers; Investigative Preclinical Toxicology) and regulatory toxicology groups (General Toxicology; Toxicology and Biometabolism). I am currently Director, Evidence-based Modeling Strategies in the Animal Research Strategy team in GSK’s Office of Animal Welfare, Ethics and Strategy. My particular interests lie in data leveraging through partnership with internal and external data efforts with the goal of supporting scientific reviews with evidence-based discussion.
I have represented GSK externally on a computational toxicology applied research project, (eTOX: Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities since 2008. This 30 partner consortium project is part of the Innovative Medicines Initiative Joint Undertaking, a unique partnership between the European Community and the European Federation of Pharmaceutical Industries and Associations.
I am the GSK representative on the NC3Rs Adverse Outcome Pathways Steering Group, set up in 2014, and in connection with that seek to increase understanding of AOPs amongst the scientific community by demonstrating how pathways-based approaches could be applied across the biosciences.
I have been a member of the BTS SSC since March 2011 and was elected as the Society’s Scientific Meetings Secretary in March 2013 and re-elected for a second term in April 2015.